Intuitive Surgical shares fell 19.9% over six months, underperforming the S&P 500. The company announced over 100 new features for its da Vinci 5 platform, including Force Feedback instruments, security upgrades, and telepresence tools to expand robotic surgery capabilities. Wall Street analysts remain moderately optimistic, citing secular healthcare tailwinds despite post-COVID inventory destocking headwinds.